Prediabetes pp 357-364 | Cite as

Immunomodulation of Pre-Diabetes in BB Rats for Prevention of the Disease

  • J. F. Markmann
  • A. Naji
  • C. F. Barker
  • K. L. Brayman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 246)


The use of insulin therapy in the treatment of diabetes was naturally heralded as a cure for this otherwise lethal malady (1). It has now become apparent that, although insulin therapy avoids the acute morbidity and mortality associated with the disease, it allows those afflicted to develop a host of chronic debilitating complications. To eliminate such complications it seems likely that more refined treatment modalities and/or effective disease prevention strategies will be necessary, and that this will require further understanding the pathogenesis of insulin dependent diabetes mellitus (IDDM).


Tolerance Model Spontaneous Diabetes Neonatal Tolerance Prediabetic Period Wistar Furth 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Banting, F.G., Best, C.H., 1922, The internal secretion of the pancreas. J. Lab. Clin. Med. 251–266.Google Scholar
  2. 2.
    Opie, E.L., 1900–1901, The relation of diabetes mellitus to lesions of the pancreas. J.Exp. Med. 5:527–540.PubMedCrossRefGoogle Scholar
  3. 3.
    VonMeyenburg, H., 1940, Ueber “Insulitus” bei diabetes. Schweiz Med. Wochenschr. 21:554.Google Scholar
  4. 4.
    Irvine, W.J., 1980, Immunological Aspects of Diabetes Mellitus: A Review (including the salient points of NDDG report on the classification of diabetes). In Immunology of Diabetes, Irvine, W.J., ed. Edinburgh, Teviot Scientific Publications, p. 1.Google Scholar
  5. 5.
    Stiller, C.R., Dupre, J., Gent, M., Venmer, M.R., Keown, P.A., I Laupacis, A., Martell, P., Rodger, N.W., Groffemed, B.V., and Wolfe, B.J.J., 1984, Effect of cyclosporine immunosuppression in insulin dependent diabetes-mellitus of recent onset. Science 223: 1363–1367.CrossRefGoogle Scholar
  6. 6.
    Marliss, E.B., Nakhooda, A.F., Poussier, P., Sima, A.A.F., 1982, The diabetic syndrome of the BB Wistar rat: possible relevance to type I I (insulin-dependent) diabetes in man. Diabetologia 22:225–232.PubMedCrossRefGoogle Scholar
  7. 7.
    Fuks, A., Colle, E., Ono, S., Prud’homme, G., Seemayer, T., and Guttman, R.D., 1988, Immunogenetic studies of insulin-dependent diabetes in the BB rat. In: Frontiers in Diabetes Research, (Shafir, E., and Renold, A.E., eds.) London, John Libbey, p. 29.Google Scholar
  8. 8.
    Like, A.A., Guberski, D.L., and Butler, L, 1986, Diabetic biobreeding/ worester (BB/Wor) rats need not be lymphopenic. J. of Immunol. 3254–58.Google Scholar
  9. 9.
    Greiner, D.L., Mordes, J.P., Handler, E.S., Angelillo, M., Nakamura, N., Rossini, A.A., 1987, Depletion of RT6. 1+ T lymphocytes induces diabetes in resistant Biobreeding/Worcester (BB/W) rats. J. Exp. Med. 166:461–75.PubMedCrossRefGoogle Scholar
  10. 10.
    Mordes, J.P., Desemone, J., Rossini, A.A., 1987, The BB rat. Diabetes/ Metabolism Reviews 3:725–750.PubMedCrossRefGoogle Scholar
  11. 11.
    Naji, A., Silvers, W.K., Bellgrau, D., Barker C.F., 1981, Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science 213:1390–1392.PubMedCrossRefGoogle Scholar
  12. 12.
    Naji, A., Silvers, W.K., Kimura, H., Bellgrau, D., Markmann, J.F., and Barker, C.F., 1983, Analytical and functional studies on the T cells of untreated and immunologically tolerant diabetes prone BB rats. J. Immunol. 130:2168–2172.PubMedGoogle Scholar
  13. 13.
    Francfort, J.W., Naji, A., Silvers, W.K., and Barker, C.F., 1985, The influence of T-lymphocyte precursor cells and thymus grafts on the cellular immunodeficiencies of the BB rat. Diabetes, Vol. 34, No. 11:1134–38.PubMedCrossRefGoogle Scholar
  14. 14.
    Brayman, K.L., Markmann, J.F., Barker, C.F., and Naji, A., 1988, Immunoprediction of diabetes and evaluation of pancreatic islet transplantation during the prediabetic period. Surgery 4:445–451.Google Scholar
  15. 15.
    Brayman, K.L., Markmann, J.F., Silvers, W.K., Barker, C.F., and Naji, A., 1987, The immunoregulation of autoimmune diabetes in BB rats is MHC-restricted. Diabetes 36 (Suppl. 1):65A.Google Scholar
  16. 16.
    Brayman, K.L., Markmann, J.F., Barker, C.F., and Naji, A., 1988, Prevention of diabetes in BB rats requires lymphocytes functionally restricted to MHC-compatible thymic determinants. Diabetes 37 (Supp. I); 55A.Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • J. F. Markmann
    • 1
  • A. Naji
    • 1
  • C. F. Barker
    • 1
  • K. L. Brayman
    • 1
  1. 1.Department of SurgeryUniversity of Pennsylvania School of MedicinePhiladelphiaUSA

Personalised recommendations